Executive Director of Clinical Development in London

Your work will change lives. Including your own.

The Impact You'll Make

Recursion is at the forefront of reimagining drug discovery through the integration of automated cell biology, high-dimensional and diverse data sets, and sophisticated analytics. You will lead program(s) across our growing pipeline of novel small molecule therapeutics in cancer while leveraging your strong track record of advancing precision medicines in Oncology from bench to POC clinical trials with scientific rigor and a thorough understanding of target and disease biology.

In this role, you will:

• Oversee the development of first-in-class/first-in-disease molecules in precision oncology
• Generate and continually refine the integrated clinical development strategy for Recursion's oncology medicine portfolio from IND to POC
• Contribute to regulatory submissions and participate in regulatory agency meetings
• Utilize strong therapeutic area expertise to enhance innovation and efficiency in clinical trial design and execution
• Deliver medical, disease-specific, and development perspective into specific research programs or broader research initiatives
• Provide scientific and medical expertise for business development assessments and due diligences

The Team You'll Join

As an Executive Director of Clinical Development you will report directly to the VP of Clinical Development. The Development Team is an empowered, execution-minded group of drug development professionals responsible for translating Recursion's innovative science to patients through clinical development activities.

The Experience You'll Need

• Medical Degree required and MD/PhD preferred
• 5+ years of experience developing, executing and analyzing Phase 1/2 Oncology trials and preferably within a biotech or pharmaceutical company
• Deep knowledge and understanding of oncology and genetic diseases; precision oncology drug development paradigms, clinical pharmacology with technical and regulatory approaches
• Strong networks and connections to external experts and key opinion leaders in oncology
• Ability to form effective collaborations with external scientific community, academia and CROs
• Effective skills directed toward driving collaboration, achieving results, influencing, and resolving conflicts across internal and external stakeholders
• Highly motivated, decisive, and results-oriented individual who is proactive, resourceful, and efficient with the flexibility and creativity to excel in and contribute to a rapidly growing drug discovery and development company

Working Location & Compensation:

This is an office-based, hybrid position at our office in London. Employees are expected to work in the office at least 50% of the time. At Recursion, we believe that every employee should be compensated fairly. Based on the skill and level of experience required for this role, the estimated current annual base range for this role is £160,600 to £192,500. You will also be eligible for an annual bonus and equity compensation, as well as a comprehensive benefits package.

The Values We Hope You Share:

• We act boldly with integrity. We are unconstrained in our thinking, take calculated risks, and push boundaries, but never at the expense of ethics, science, or trust. We care deeply and engage directly.
• We learn actively and adapt rapidly. Progress comes from doing. We experiment, test, and refine, embracing iteration over perfection.
• We move with urgency because patients are waiting. Speed isn't about rushing but about moving the needle every day.
• We take ownership and accountability. Through ownership and accountability, we enable trust and autonomy - leaders take accountability for decisive action, and teams own outcomes together. We are One Recursion.

Our values underpin the employee experience at Recursion. They are the character and personality of the company demonstrated through how we communicate, support one another, spend our time, make decisions, and celebrate collectively.

More About Recursion

Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world's largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale - up to millions of wet lab experiments weekly - and massive computational scale - owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.

Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montréal, New York, London, Oxford area, and the San Francisco Bay area.

Recursion is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected under applicable federal, state, local, or provincial human rights legislation. Accommodations are available on request for candidates taking part in all aspects of the selection process.

Recruitment & Staffing Agencies: Recursion Pharmaceuticals and its affiliate companies do not accept resumes from any source other than candidates. The submission of resumes by recruitment or staffing agencies to Recursion or its employees is strictly prohibited unless contacted directly by Recursion's internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of Recursion, and Recursion will not owe any referral or other fees. Our team will communicate directly with candidates who are not represented by an agent or intermediary unless otherwise agreed to prior to interviewing for the job.